Syn2bio S.A. (WSE:S2B)
Poland · Delayed Price · Currency is PLN 30.67
-1.33 (-4.16%)
Last updated: Apr 28, 2026, 2:25 PM CET
Syn2bio Market Cap
Syn2bio has a market cap or net worth of 279.33 million as of April 28, 2026.
Market Cap
279.33M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
30.67
Market Cap Chart
Since April 16, 2026, Syn2bio's market cap has decreased from 311.63M to 279.33M, a decrease of -10.36%. That is a compound annual growth rate of -97.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 279.33M | -2.14% |
| Apr 24, 2026 | 285.44M | -7.10% |
| Apr 23, 2026 | 307.27M | 4.39% |
| Apr 22, 2026 | 294.35M | -9.38% |
| Apr 21, 2026 | 324.81M | -8.01% |
| Apr 20, 2026 | 353.09M | -5.25% |
| Apr 17, 2026 | 372.65M | 19.58% |
| Apr 16, 2026 | 311.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ryvu Therapeutics | 544.48M |
| Captor Therapeutics Spolka Akcyjna | 512.08M |
| Bioceltix | 427.44M |
| BIOTON | 358.91M |
| Synthaverse | 242.74M |
| Mabion | 132.85M |
| Molecure | 120.12M |
| NanoGroup | 108.28M |